ArticleBMC health services research2015

Cost-effectiveness of adding rituximab to splenectomy and romiplostim for treating steroid-resistant idiopathic thrombocytopenic purpura in adults.

Kayoko Kikuchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.